Amlodipine Besylate/Perindopril Arginine

苯磺酸氨氯地平/精氨酸培哚普利

Report date: 2022/03/08 16:45:32

Base Information

Drug NameAmlodipine Besylate/Perindopril Arginine
Drug Alias Nameperindopril arginine and amlodipinePerindopril Arginine/Amlodipine BesylateAmlodipine Besylate and Perindopril Arginineperindopril arginine + amlodipine besylatePrestalia +[6] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAngiotensin-converting enzyme
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date2015/01/21
Country/TerritoryUnited StatesMainland China
CombinationsYes Amlodipine BesylatePerindopril Arginine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSymplmed
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier
Inactive CompaniesAdhera Therapeutics Inc
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09BB04
Related LinksN/A